Portfolio
Hy2Care secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion
14.05.2025
Our progress journal.
Portfolio
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
17.04.2025
Portfolio
Grassa Raises €3.6M; Grass Protein Consumption by Humans Draws Closer
19.03.2025
Portfolio
Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology
19.02.2025
Portfolio
Matisse Pharmaceuticals receives BfArM approval to study a prolonged infusion of M6229
24.10.2024
Portfolio
Matisse Pharmaceuticals appoints Prof. Carolyn Calfee to the Scientific Board
22.10.2024
Portfolio
Bio-Engineering scale-up Qorium unveils cultivated leather breakthrough, marking major progress toward commercialization
15.10.2024
Portfolio
PL BioScience closes €7.8M Series A Financing
08.08.2024
Portfolio
Vivalyx secures seed financing to improve donor organ quality
30.04.2024
Portfolio
Funding for TripleMed to achieve CE marking
21.03.2024
Portfolio
Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients
30.01.2024
Portfolio
Verdify secures €2.4 million investment for impactful food choices in healthcare and retail
24.01.2024
Portfolio
Funding of Ioniqa’s enhanced recycling business of PET Polyester
23.01.2024
Portfolio
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners
10.01.2024
Portfolio
AGI Group Acquires Chemtrix B.V. to Expand into the Large-scale Flow Chemistry Market
04.01.2024
Portfolio
Matisse Pharmaceuticals closes €3.6M financing round
04.01.2024
Portfolio
Corporis Medical closes €4M Series B financing round
07.12.2023